Asad Haider Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Asad Haider

Stock Analyst at Goldman Sachs

(4.51)
# 1512
Out of 5,506 analysts
10
Total ratings
Success rate
Average return

10 Stocks

Name Action PT Current % Upside Ratings Updated
INVA Innoviva
Initiates Coverage On: Sell
17
17.48 -2.75% 1 Sep 30, 2025
RPRX Royalty Pharma
Initiates Coverage On: Buy
42
36.07 16.44% 1 Sep 30, 2025
PCVX Vaxcyte
Initiates Coverage On: Neutral
38
42.66 -10.92% 1 Sep 12, 2025
NAMS NewAmsterdam Pharma ...
Initiates Coverage On: Neutral
27
30.67 -11.97% 1 Jul 17, 2025
BNTX BioNTech
Initiates Coverage On: Neutral
110
105.49 4.28% 1 May 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
157 172
188.64 -8.82% 1 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
892 888
840.01 5.71% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
194
233.87 -17.05% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 25
27.36 -8.63% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
67 55
45.44 21.04% 1 Apr 8, 2025